Skip to main
MASI

Masimo (MASI) Stock Forecast & Price Target

Masimo (MASI) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Masimo Corp's positive outlook is supported by a robust growth trajectory within its core pulse oximetry business as well as significant advancements in advanced monitoring technologies, including capnography and hemodynamics, driving increased revenue. The company is expected to achieve consistent earnings before interest and taxes (EBIT) margin expansion, projected at approximately 70 and 60 basis points year-over-year growth for fiscal years 2026 and 2027, indicating improving profitability. With anticipated revenue growth rates exceeding 10% in both the international pulse oximetry market and from new product launches in advanced monitoring platforms, Masimo's long-term financial prospects appear strong.

Bears say

Masimo Corporation faces significant financial headwinds, including projected tariff impacts of approximately $16 million to $17 million for FY25, which could adversely affect operating margins by around 110 basis points. The company’s cautious revenue forecasts are compounded by various risks, such as increased competition, pressures on hospital demand for capital equipment, and potential delays related to regulatory approvals and product launches. Furthermore, vulnerabilities in sales force retention and integration of mergers and acquisitions add layers of uncertainty, suggesting challenges in achieving sustainable revenue growth and profitability in the healthcare sector.

Masimo (MASI) has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Masimo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Masimo (MASI) Forecast

Analysts have given Masimo (MASI) a Buy based on their latest research and market trends.

According to 5 analysts, Masimo (MASI) has a Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $187.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $187.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Masimo (MASI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.